We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




PET Scans Reveal Hidden Inflammation in Multiple Sclerosis Patients

By MedImaging International staff writers
Posted on 30 Apr 2024
Print article
Individualized parametric z-score maps of the brain showing glial activity load on PET (GALP) in the brain, compared among secondary progressive MS (SPMS, top row), relapsing remitting MS (RRMS, middle row), and healthy controls (HC, bottom row) in transaxial, sagittal, and coronal sections (Photo courtesty of Singhal et al., Clinical Nuclear Medicine 2024)
Individualized parametric z-score maps of the brain showing glial activity load on PET (GALP) in the brain, compared among secondary progressive MS (SPMS, top row), relapsing remitting MS (RRMS, middle row), and healthy controls (HC, bottom row) in transaxial, sagittal, and coronal sections (Photo courtesty of Singhal et al., Clinical Nuclear Medicine 2024)

A key challenge for clinicians treating patients with multiple sclerosis (MS) is that after a certain amount of time, they continue to worsen even though their MRIs show no change. A new study has now revealed that advanced brain imaging can detect hidden inflammation in MS patients which traditional MRIs fail to pick up, potentially leading to improved treatment strategies.

Researchers from Brigham and Women’s Hospital (Boston, MA, USA) have discovered that positron emission tomography (PET) brain scans can identify hidden inflammation in patients undergoing treatment with highly effective MS therapies. This finding emerged when the research team noted that patients on the most effective MS treatments still experienced symptom progression. Over the past eight years, they have developed a technique to image microglia, immune cells in the brain involved in MS progression, which are not visible on routine MRIs. They utilized 18F-PBR 06 PET imaging, which uses a tracer binding to microglia cells, revealing that increased microglial activity is associated with greater atrophy of gray matter in the brain, impacting cognition, movement, and fine motor skills.

The researchers have coined the term “smoldering” inflammation, comparing it to a smoldering fire that burns slowly without emitting any smoke or flame but continues to cause damage despite showing no signs on MRI. They conducted PET scans on 22 MS patients and eight healthy controls, measuring glial activity load, a new measure developed by the researchers to assess the level of smoldering inflammation from microglia. They found that PET scans showed the hidden inflammation caused by microglia missed by MRI, and the damage to patients’ brains correlated with the patients' levels of disability and fatigue.

Furthermore, the study allowed the researchers to successfully differentiate between patients on high-efficacy and low-efficacy MS treatments. Those on low-efficacy treatments exhibited more PET scan abnormalities, indicating increased microglial activation. Conversely, patients on high-efficacy treatments showed fewer abnormalities but still displayed increased microglial activity compared to healthy individuals. This suggests that while high-efficacy treatments reduce neuroinflammation, residual inflammation persists and may contribute to the worsening of symptoms known as progression independent of relapse activity (PIRA). This research underscores the significant potential of PET scanning in detecting microglial activation, offering critical insights into managing MS more effectively.

“Our therapies are excellent in that we’ve definitely improved MS patients’ lives,” said Rohit Bakshi, MD, of the Department of Neurology. “There’s no doubt about that, but we’re still not at the finish line. This study tells us something new about the disease and may be giving us an important clue as to what is driving disease progression in patients.”

Related Links:
Brigham and Women’s Hospital


Print article
Radcal

Channels

Radiography

view channel
Image: Physicians using the Zenition 90 Motorized mobile X-ray system (Photo courtesy of Royal Philips)

High-Powered Motorized Mobile C-Arm Delivers State-Of-The-Art Images for Challenging Procedures

During complex surgical procedures, clinicians depend on surgical imaging systems as they navigate challenging anatomy to quickly visualize small anatomical details while minimizing X-ray exposure.... Read more

Ultrasound

view channel
Image: The device creates microbubbles that temporarily disrupt the BBB, permitting the entry of immunotherapy into the brain (Photo courtesy of Northwestern)

Ultrasound Technology Breaks Blood-Brain Barrier for Glioblastoma Treatment

Despite extensive molecular studies, the outlook for patients diagnosed with the aggressive brain cancer known as glioblastoma (GBM) continues to be poor. This is partly due to the blood-brain barrier... Read more

Nuclear Medicine

view channel
Image: 68Ga-NC-BCH whole-body PET imaging rapidly targets an important gastrointestinal cancer biomarker in lesions in GI cancer patients (Photo courtesy of Qi, Guo, et al.; doi.org/10.2967/jnumed.123.267110)

New PET Radiotracer Enables Same-Day Imaging of Key Gastrointestinal Cancer Biomarker

Gastrointestinal cancers rank among the most prevalent cancers worldwide, contributing to over a quarter of all cancer cases and over one-third of cancer-related deaths annually. The initial symptoms of... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.